AngioInsight, Inc.
PrivateLast Round
Series A
Oct 23, 2025
Est. Valuation
$100M
Total Funding Raised
$26.02M
Company Overview
AngioInsight, Inc. operates in Healthcare & Life Sciences and is based in Minnetonka, Minnesota. Its latest recorded funding round was a Series A round in October 2025.
AngioInsight, Inc. is a medical technology company that develops AI-driven software solutions for the diagnosis and management of cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Medical Devices
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AngioInsight, Inc. Comparables
Compare AngioInsight, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medipixel | 91% | |
| MedHub-AI | 85% | |
| Esaote | 81% |
For institutional investors. Book with your work email.
AngioInsight, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 23, 2025 | ||||
| Grant | Jun 15, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AngioInsight, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avestria Ventures | Series A |
| Ann Arbor SPARK | Grant |
| Innovation Partnerships | Series A |
| Michigan Translational Research and Commercialization (MTRAC) Program | Grant |
| Dakota Venture Group | Seed |
| Gopher Angels | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors grew 89% MoM.
- May 16, 2026
Monthly visitors increased 63% MoM.
For institutional investors. Book with your work email.
AngioInsight, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AngioInsight, Inc.'s valuation, stock price, and market status.
Is AngioInsight, Inc. a public or private company?
AngioInsight, Inc. is a private company.
What is the current stock price of AngioInsight, Inc.?
AngioInsight, Inc. is a private company, so its shares have no public market price. Caplight tracks AngioInsight, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AngioInsight, Inc. worth (valuation)?
AngioInsight, Inc.'s valuation is estimated at $100.0M based on funding round data.
Can I buy AngioInsight, Inc. stock?
AngioInsight, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AngioInsight, Inc.'s last funding round?
AngioInsight, Inc.'s most recent funding round was Series A on October 23, 2025.
Who are the main investors in AngioInsight, Inc.?
Key investors in AngioInsight, Inc. include Avestria Ventures, Ann Arbor SPARK, Innovation Partnerships, Michigan Translational Research and Commercialization (MTRAC) Program, Dakota Venture Group.
Will AngioInsight, Inc. IPO soon?
No public IPO plans have been announced for AngioInsight, Inc..
How can I track AngioInsight, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in AngioInsight, Inc.'s shares on secondary markets.